AI in healthcare: revolutionizing medicine or overhyped promise? | Forbes
Excerpt from Forbes: “AI is going to change healthcare forever. In the near future, we can look forward to revolutionary new cures and treatments, personalized medicine, and a new generation of hospitals and facilities where super-smart robots take care of everything from cleaning to brain surgery. At least – so we’re told.” Read more.
Columbus drug manufacturer to produce critical drug amid shortage | Columbus Dispatch
Excerpt from Columbus Dispatch: “More children battling cancer will have access to a drug that could be critical to their survival, thanks to a Columbus manufacturer doing its part to combat a national drug shortage. STAQ Pharma, a Denver-based pharmaceutical supplier focusing on acute shortages in critical medications, announced the launch of its oncology drugs portfolio at its Columbus location Friday.” Read more.
Teva Pharma raises 2024 targets on strength in generic, branded drugs | Reuters
Excerpt from Reuters: “Teva Pharmaceutical Industries raised its annual forecasts on Wednesday, as it benefits from strong demand for its cheaper copycat medicines and branded treatment for Huntington’s disease. The company is banking on its branded medicine trio — Austedo for treating Huntington’s disease, Ajovy for migraine and recently launched Uzedy for schizophrenia — to drive future growth. It lifted the annual revenue forecast for Austedo by $100 million to about $1.6 billion.” Read more.
Sorry, the comment form is closed at this time.